Judge Rejects Merck's Challenge to Medicare Drug Price Negotiations

A DC federal judge has rejected Merck's challenge to Medicare drug price negotiations. The decision was made by Judge Colleen Kollar-Kotelly on Monday, August 24, 2026.

The case had been ongoing for more than three years, with the company seeking to overturn a policy that allows Medicare to negotiate prices for certain prescription medications.

Merck's challenge was based on concerns that the policy would be overly burdensome and infringe on the company's rights as a pharmaceutical manufacturer.